Condition: Tricuspid Regurgitation · Tricuspid Valve Insufficiency · Tricuspid Valve Disease · Sponsor: CroiValve Limited
The study is an early feasibility study to measure individual patient clinical outcomes and effectiveness, evaluate the safety and function of the DUO Transcatheter Tricuspid Coaptation Valve System (DUO System).
This description comes directly from the study's public registry record.
Helen Scotch · 612-229-9950 · Helen@CroiValve.com
Aubrey Dyer · 916-768-9141 · Aubrey@CroiValve.com
Always discuss trial participation with your own doctor first.
| Dignity Health St. Joseph's Hospital & Medical Center | Phoenix, Arizona, United States | Recruiting |
| Los Robles Hospital & Medical Center | Thousand Oaks, California, United States | Recruiting |
| Piedmont Heart Institute | Atlanta, Georgia, United States | Recruiting |
| Northwestern University | Chicago, Illinois, United States | Recruiting |
| Ascension Via Christi Research | Wichita, Kansas, United States | Recruiting |
| Allina Health Minneapolis Heart Institute Foundation | Minneapolis, Minnesota, United States | Recruiting |
| Columbia University Medical Center/NYPH | New York, New York, United States | Recruiting |
| OhioHealth Research Institute | Columbus, Ohio, United States | Recruiting |
| UPMC Pinnacle Harrisburg | Harrisburg, Pennsylvania, United States | Recruiting |
| San Antonio Methodist | San Antonio, Texas, United States | Enrolling By Invitation |
| Intermountain Health | Salt Lake City, Utah, United States | Recruiting |
| University of Washington | Seattle, Washington, United States | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05913908